Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.66 |
| ▸ | NPC1 | O15118 | 8/20 | 0.66 |
| ▸ | RAB9A | P51151 | 8/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.66 |
| ▸ | HPGD | P15428 | 3/20 | 0.66 |
| ▸ | CASP3 | P42574 | 2/20 | 0.66 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.66 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.66 |
| ▸ | POLB | P06746 | 2/20 | 0.66 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | TP53 | P04637 | 3/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.52 |
| ▸ | PTPN5 | P54829 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29407356 | 1.00 | SMN1; SMN2 (0.66) | SMN1; SMN2NPC1RAB9AKDM4EHPGD | |
| SCHEMBL25498923 | 0.97 | SMN1; SMN2 (0.62) | SMN1; SMN2NPC1RAB9AKDM4EHPGD | |
| SCHEMBL10173054 | 0.89 | HDAC6 (0.64) | SMN1; SMN2NPC1RAB9AKDM4EHPGD | |
| SCHEMBL2139699 | 0.86 | SMN1; SMN2 (0.57) | SMN1; SMN2NPC1RAB9AKDM4EHPGD | |
| SCHEMBL1026557 | 0.85 | PIK3CB (0.67) | SMN1; SMN2NPC1RAB9AKDM4EHPGD | |
| SCHEMBL29780606 | 0.85 | PIK3CB (0.67) | SMN1; SMN2NPC1RAB9AKDM4EHPGD | |
| SCHEMBL3722175 | 0.84 | TP53 (0.61) | SMN1; SMN2NPC1RAB9AKDM4EHPGD | |
| SCHEMBL13528498 | 0.84 | NPC1 (0.72) | SMN1; SMN2NPC1RAB9AKDM4EHPGD | |
| SCHEMBL2247467 | 0.83 | RAB9A (0.76) | SMN1; SMN2NPC1RAB9AKDM4EHPGD | |
| SCHEMBL11382720 | 0.83 | SMN1; SMN2 (0.51) | SMN1; SMN2NPC1RAB9AKDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240237514-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER | LT MATERIALS CO., LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240237514-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER | LT MATERIALS CO., LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| EP-4063368-B1 | NITROGEN-CONTAINING COMPOUND AND ELECTRONIC ELEMENT COMPRISING SAME, AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MAT CO LTD (CN) | 2024-06-26 | — | — | EP | disclosed |
| CN-118165007-A | Condensed ring compound, application thereof and organic electroluminescent device | 北京绿人科技有限责任公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-113972332-B | Organic electroluminescent device and electronic device including the same | 陕西莱特光电材料股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-114933595-B | 2-Phenylbenzoxazole multi-stimulus response fluorescent material and preparation method thereof | 长春工业大学 | 2024-04-30 | — | — | CN | disclosed |
| EP-4324831-A1 | ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | Shaanxi Lighte Optoelectronics Material Co., Ltd. (CN) | 2024-02-21 | — | — | EP | disclosed |
| WO-2023172110-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-09-14 | — | — | WO | disclosed |
| WO-2023172110-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-09-14 | — | — | WO | disclosed |
| US-20230217814-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-10889901-B2 | Ultraviolet-stabilized corrosion inhibitors | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-01-12 | — | — | US | disclosed |
| CN-112028853-A | Arylamine derivative and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2020-12-04 | — | — | CN | disclosed |
| US-20200032401-A1 | ULTRAVIOLET-STABILIZED CORROSION INHIBITORS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2020-01-30 | — | — | US | disclosed |
| WO-2018043913-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 주식회사 두산 | 2018-03-08 | — | — | WO | disclosed |
| WO-2015111943-A1 | ORGANIC COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME | 주식회사 두산 | 2015-07-30 | — | — | WO | disclosed |
| WO-2015111943-A1 | ORGANIC COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME | 주식회사 두산 | 2015-07-30 | — | — | WO | disclosed |
| US-9006450-B2 | Compounds, pharmaceutical compositions and uses thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2015-04-14 | — | — | US | disclosed |
| US-9006450-B2 | Compounds, pharmaceutical compositions and uses thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2015-04-14 | — | — | US | disclosed |
| US-20120157425-A1 | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-06-21 | — | — | US | disclosed |
| US-20120157425-A1 | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10889901-B2 | Ultraviolet-stabilized corrosion inhibitors | TYR, UNG, MGMT | SMN1; SMN2 3108/4885NPC1 4864/4885RAB9A 2203/4885 |
| US-20200032401-A1 | ULTRAVIOLET-STABILIZED CORROSION INHIBITORS | TYR, UNG, MGMT | SMN1; SMN2 3108/4885NPC1 4864/4885RAB9A 2203/4885 |
| US-20120157425-A1 | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | P2RX5, P2RX3, ABCG2 | SMN1; SMN2 4388/4885NPC1 350/4885RAB9A 2252/4885 |
| US-20230217814-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | AOX1, XDH, PPOX | SMN1; SMN2 4240/4885NPC1 1470/4885RAB9A 3117/4885 |
| US-20240237514-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER | CYP1A1, CYP1B1, CYP2E1 | SMN1; SMN2 3276/4885NPC1 1364/4885RAB9A 2863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.